Sino Biopharmaceutical Limited (1177) 📈: отчетность и дивиденды за 2025

Reports

IFRS

Reporting Annual Quarterly

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Financial report	link	link	link	link	link	link	link	link	link	link

Capitalization

IFRS

Reporting Annual Quarterly

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Average for 5 years	CAGR 5
Capitalization, bln ¥	519.78	231.4	325.47	426.57	248.4	257.15	134.08	83.61	70.08		125.88
Revenue, bln ¥		14.17	14.82	20.89	24.23	23.65	26.86	25.41	26.72	26.77	26.66
Net profit, bln ¥		1.71	2.17	9.05	2.71	2.77	14.61	4.42	2.38	3.25	3.23
EV, bln ¥		230.68	324.24	423.31	245.04	260.25	129.01	80.3	57.66	55.01	54.79
EBIT, bln ¥		2.89	3.27	4.57	5.25	4.3	4.23	5.91	6.02	4.79	4.77
EBITDA, bln ¥		3.24	3.61	5.75	6.72	5.96	18.88	6.83	7.12	5.66	5.64
OIBDA, bln ¥						7.09	24.11	8.32	10.64	8.24	8.21
Book value, bln ¥		7.9	9.21	29.21	31.11	16.75	30.29	29.75	31.08	31.54	31.41
FCF, bln ¥		2.16	2.27	3.4	3.59	3.47	3.47	4.56	4.45	4.84	4.82
Operating Cash Flow, bln ¥		3.09	3.73	5.09	5.32	5.33	5.37	6.27	6.19	6.13	6.11
Operating profit, bln ¥		2.89	3.27	4.57	5.25	4.3	5.25	5.91	5.9	5.83	5.8
Operating expenses, bln ¥		8.33	8.46	12.12	14.06	19.34	22.52	14.97	15.73	15.87	15.8
CAPEX, bln ¥		0.9352	1.46	1.69	1.73	1.86	1.71	1.71	1.74	1.29	1.29

	2018Q4	2019Q1	2019Q2	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	Average for 5 quarters	CAGR 5
Capitalization, bln ¥				350.39	221.2	145.48	148.94	155.84	106.88		79.29		78.93		75.53		61.43
Revenue, bln ¥											15.19	6.79	13.59	7.64	7.64		10.09	7.3	7.36	6.02	6.02
Net profit, bln ¥											1.92	0.3113	0.6225	0.6294	0.6294		0.9912	1.39	1.4	0.2238	0.2238
EV, bln ¥											95.67		83.65	71.26	58.83		57.58	53.73	46.63	63.09	54.66	88.01
EBIT, bln ¥										1.58	1.58	1.36	0.8648	1.56	1.56			1.6	1.61	0.7878	0.7878
EBITDA, bln ¥					1.28	0.9145						1.61	1.11	1.87	1.87			1.82	1.83	1.01	1.01
OIBDA, bln ¥												2.65	2.15	2.8	2.8			2.09	2.1	2.03	2.03
Book value, bln ¥													29.75	29.99	29.99	30.47	30.47	30.22	30.46	29.64	29.64	33.91
FCF, bln ¥	0.8977	0.8977	0.8977								1.66	0.8499	0.8499	0.9586	0.9586			1.23	1.24
Operating Cash Flow, bln ¥									1.52	1.97	1.97	1.34	1.34	1.34	1.34		5.6	1.42	1.43
Operating profit, bln ¥											3.42	1.36	2.95	1.56	1.56		2.48	1.66	1.67	1.24	1.24
Operating expenses, bln ¥					4.37	3.66						4.38	3.46	4.4	4.4			4.34	4.37	3.63	3.63
CAPEX, bln ¥									0.5737	0.3135	0.3135	0.377	0.377	0.377	0.377		0.9862	0.1874	0.1889

	Average for 5 quarters	CAGR 5

Cash flow Cash flow quarterly Assets

Balance sheet

IFRS

Reporting Annual Quarterly

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Average for 5 years	CAGR 5
Cash, bln ¥				3.76	4.19	6.68	11.91	11.26	10.57	8.65	9.64	9.44	9.41
Short-Term Investments ¥				2.53	3.59	2	1.58	4.22	4.66	8.27	1.58	4.96	4.94
Long-Term Investments ¥	1.26	1.79	1.85	1.41	1.78	1.07
Accounts Receivable ¥				3.09	2.74	3.87	3.34	3.04	3.28	4.64	4.69	4.9	4.88
Total Current Assets ¥				12.73	13.78	18.54	24.91	22.79	23.5	25.93	24.28	24.36	24.26
Net assets, bln ¥				2.69	3.48	5.8	8.21	8.39	8.52	9.25	31.08	31.54	10.11
Assets, bln ¥				18.39	20.94	49.78	58.3	47.21	60.54	64.06	64.87	64.55	64.29
Short-Term Debt ¥				1.37	0.7413	2.91	0.6667	1.55	0.1361	9.72	11.43	7.6	7.57
Long-Term Debt ¥				1.68	2.21	0.5071	7.88	12.8	5.37	4.26	1.4	2.05	2.04
Liabilities, bln ¥				7.7	8.32	12.23	18.01	24.79	30.25	26.12	25.94	22.34	22.25
Net debt, bln ¥				-0.717	-1.24	-3.26	-3.36	2.66	1.16	5.33	3.19	0.2115	0.2106
Debt, bln ¥				3.05	2.95	3.41	8.55	14.36	5.5	13.98	12.83	9.66	9.62
Interest Income ¥			0.2082	0.2208	0.3311	0.0934	0.1186	0.194	13.32	0.592	0.1867
Interest Expense, bln ¥				0.1873	0.5695	0.1533	0.23	0.3234	0.3086	0.3877	0.5051	0.1359	0.1353
Net interest income, bln ¥				-0.0395	0.0051	0.0095	0.0278	-0.1294	-0.1466	-0.2376	-0.3086		0.2046
Goodwill ¥		0.0886	0.0927	0.099	0.0889	13.9	13.9	0.0889	0.6479	0.6626	0.6805
Amortization, bln ¥				0.3531	0.3434	1.18	1.47	1.65	0.9926	0.9244	1.1	0.8716	0.868
Cost of production, bln ¥				2.95	3.09	4.2	4.93	5.18	5.33	5.12	5.09	4.95	4.93
Inventory ¥				0.8946	0.9188	1.21	1.66	1.88	1.94	2.33	2.03	2.34	2.33

	2016Q4	2017Q2	2017Q4	2018Q2	2018Q4	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	Average for 5 quarters	CAGR 5
Cash, bln ¥																		6.41	11.58	11.58	9.45	9.45	7.87	7.93	8.87	8.87	11.28
Short-Term Investments ¥																		8.27	0.1601	4.1	1.55	4.67	4.26	4.29	4.66	4.66	8.86
Long-Term Investments ¥	1.58	1.71	1.78	1.18	1.07	1.21
Accounts Receivable ¥																		4.64	7.19	7.11	4.6	4.6	6.72	6.77	4.61	4.61	8.29
Total Current Assets ¥																		25.93	26.98	26.98	23.81	23.81	23.2	23.39	22.89	22.89	34.37
Net assets, bln ¥																8.77		9.25	9.58	9.58		10.07	30.22	30.46	29.64	29.64	33.91
Assets, bln ¥																		64.06	65.64	65.64	63.6	63.6	61.37	61.86	60.66	60.66	76.11
Short-Term Debt ¥																		9.72	10.48	10.52	11.27	11.21	7.83	7.89	7.14	7.14	9
Long-Term Debt ¥													12.77	11.97	5.37	7.63		3.93		1.03		1.07		1.08		1.93	3.05
Liabilities, bln ¥																		34.32	29.18	29.18	25.43	25.43	22.61	22.8	20.99	20.99	29.59
Net debt, bln ¥																		4.94	-0.0609	-0.0231	3.19	3.13	0.8847	1.05	0.1987	0.1987	0.76
Debt, bln ¥																		13.98	11.52	11.55	12.64	12.58	8.75	8.97	9.07	9.07	12.05
Interest Income ¥									0.0879	0.1276	0.1367	0.3266	1.4	7.44	13.32	0.3339		0.9259		0.5236
Interest Expense, bln ¥												0.0579	0.1257	0.081	0.2582	0.1805		0.0172		0.3138		0.1893		0.1837		0.0478
Net interest income, bln ¥							0.0059	0.0052	-0.0131	-0.0084	-0.0367	-0.0712			13.32	0.3592		0.9962		0.5633
Goodwill ¥										13.9	13.9	0.0889	0.8908	0.906	0.6479	0.6426		0.6626		0.8121		0.6805
Amortization, bln ¥						0.3665											0.2464	0.2464	0.3057	0.3057	0.0000		0.2213	0.2231	0.2231	0.2179
Cost of production, bln ¥																2.96	1.42	2.84	1.63	1.63		1.6	1.31	1.32	1.16	1.16
Inventory ¥																		2.33	2.02	2.02	1.99	1.99	1.69	1.7	2.2	2.2	2.14

	Average for 5 quarters	CAGR 5

Share

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Average for 5 years	CAGR 5
EPS	0.17	0.19	0.18	0.17	0.16	0.71	0.2323	0.1284	0.1774		0.1767
Share price		31.19	7.74	16.35	7.5	5.46	4.57	3.47	3.22	7	7
Number of shares, mln	18873.49	18873.49	18873.49	18873.49	18861.5	18839.59	19017.2	17183.32	16966.32		16897.16
FCF/share	0.1142	0.1204	0.1802	0.1902	0.1838	0.1843	0.2398	0.2589	0.2854		0.2854

	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	2025Q3	2025Q4	Average for 5 quarters	CAGR 5
EPS												0.085	0.1021		0.098	0.0339	0.0339		0.0527	0.0751	0.076	0.0123	0.0123
Share price													4.21	4.35	4.27	4.46	4.02	3.18	3.27					4.94	8.46	7
Number of shares, mln						18872.63	18872.63	18861.5	18861.5	18861.5	18839.59		18815.19		18468.07		18809.22		18801.22
FCF/share	0.0487	0.0451	0.0476	0.0475	0.0476										0.0449	0.0516	0.0516			0.0723	0.0725

	Average for 5 quarters	CAGR 5

Efficiency

IFRS

Reporting Annual Quarterly

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Industry average	Average for 5 years	CAGR 5
ROE, %			21.67	23.57	30.97	8.7	16.55	48.23	14.71	7.66	10.3		10.37	8.07
ROA, %			9.32	10.37	18.17	4.64	5.87	24.13	7.09	3.67	5.03		5.02	5.46
ROIC, %	17.79	21.64	19.28	21.55	29.91	8.89	12.73	43.44	11.55	9.31
ROS, %				14.65	43.31	11.17	11.72	54.38	17.38	8.91	12.14	12.12	12.12	10.56
ROCE, %				25.92	12.18	13.04	19.2	13.96	13.45	15.46	11.35	11.35	11.35	5.34
EBIT margin						23.97	20.67	70.21	23.25	22.53	17.89	17.89	17.89	10.16
EBITDA margin				24.38	27.52	27.72	25.2	70.29	26.88	26.65	21.14	21.16	21.16	11.04
Net margin			12.09	14.65	43.31	11.17	11.72	54.38	17.38	8.91	12.14		12.12	10.56
Operational efficiency, %				22.06	21.89	21.67	18.2	19.55	23.25	22.08	21.78	21.76	21.76	13.91
FCF yield, %		0.1537	0.9316	0.6982	0.7974	1.45	1.35	2.59	5.45	6.22			3.83	2.92

	2016Q2	2016Q4	2017Q1	2017Q2	2017Q4	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	2025Q3	2025Q4	Industry average	Average for 5 quarters	CAGR 5
ROE, %											48.23	6.36		2.09	2.1	2.11	3.23	4.6	4.6	0.7551	0.7551				8.07
ROA, %											24.13	2.96		0.9717	0.9588	0.9588	1.55	2.26	2.26	0.3689	0.3689				5.46
ROIC, %	5.28	4		5.62	4.47		3.27	21.61	3.21	2.39				1.05			3.6
ROS, %															8.24	8.24	9.82	19.04	19.02	3.72	3.72	12.12	12.12	12.12	10.56
ROCE, %												5.23		2.28	4.29	3.78		4.13	4.12	1.99	1.99		11.35	11.35	5.34
EBIT margin													20.01	21.41	20.46	20.46		21.92	21.88	13.09	13.09		17.89	17.89	10.16
EBITDA margin														27.51	24.46	24.46		24.93	24.86	16.78	16.78	25.15	21.16	21.16	11.04
Net margin												12.64	4.58	4.58	8.24	8.24	9.82	19.04	19.02	3.72	3.72				10.56
Operational efficiency, %															20.46	20.46	24.58	22.74	22.69	20.6	20.6	22.24	21.76	21.76	13.91
FCF yield, %	0.2373	0.2433	0.2394	0.2005	0.1909	0.1469	0.137	0.4739	0.4901	0.4162															2.92

	Industry average	Average for 5 quarters	CAGR 5

Coefficients

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Industry average	Average for 5 years	CAGR 5
P/E	135.07	149.92	47.15	91.77	92.8	9.18	16.97	22.9	16.88		16.88	-156.93
P/BV	29.27	35.34	14.6	7.98	15.35	4.43	1.98	1.4	1.3		1.3	2.77
P/S	16.33	21.96	20.42	10.25	10.87	4.99	2.95	2.04	2.05		2.05	5.18
P/FCF		143.23	125.4	69.18	74.19	38.61	18.34	16.07	13.53	26.12	26.12	-5.49
E/P		0.0067	0.0212	0.0109	0.0108	0.109	0.0304	0.0333	0.0395	0.0257	0.0257	0.03
EV/EBIT				31.02	24.95	4.68	13.59	9.58	11.48	11.49	11.49	14.21
EV/EBITDA	71.16	89.75	73.63	36.48	43.67	6.83	11.75	8.1	9.72		9.71	10.36
EV/S		21.88	20.27	10.11	11.01	4.8	3.16	2.16	2.05	2.06	2.06	10.01
EV/FCF		142.69	124.44	68.24	75.08	37.15	17.61	12.96	11.37	11.37	11.37	-22.89
Debt/EBITDA		0.8169	0.5936	1.27	2.41	0.2914	2.05	1.8	1.71	1.71	1.71	0.25
Netdebt/EBITDA		-0.3424	-0.5676	-0.5001	0.4459	0.0617	0.7798	0.448	0.0374	0.0373	0.0373	-1.80
Debt/Ratio		0.141	0.0686	0.1467	0.3041	0.0909	0.2182	0.1978	0.1497	0.1496	0.1496	0.10
Debt/Equity		0.3205	0.1168	0.2749	0.8572	0.1816	0.47	0.4128	0.3063	0.5293	0.5293	0.56
Debt/Net Income		1.36	0.3772	3.16	5.18	0.3766	3.17	5.39	2.97	2.98	2.98	-1.81
PEG										-124.65	-124.65	-1308.27
Beta								-1.34	0.6168	-0.0861	-0.0861	1.09
Altman Index		18.39	10.27	4.51	9.43	8.86	3.57	3.07	3.94	32.04	32.04	7.58

	2017Q2	2017Q4	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q4	2021Q1	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	Industry average	Average for 5 quarters	CAGR 5
P/E															7.32	41.27		126.79	42.02	42.21		23.93	17.22	12.1	15.94	16.98					-156.93
P/BV															3.53	2.62		2.65	1.96	1.61		1.43	1.32	1.17	1.59	1.37					2.77
P/S															3.98	5.22		5.81	2.78	2.27		2.12	2.08	1.85	2.07	2.05					5.18
P/FCF	498.82	523.89	680.55	730.03	211.02	204.04	240.26																					11.31	26.12	26.12	-5.49
E/P												0.0063	0.0128	0.0544	0.1367	0.0242		0.0079		0.0167								0.0593	0.0257	0.0257	0.03
EV/EBIT																		92.37	45.6	37.65			33.58	28.96	80.08	69.38			11.49	11.49	14.21
EV/EBITDA											253.17	162.46					10.62	71.89	38.14	9.12			29.52	25.48	62.47	54.12					10.36
EV/S																			9.33	7.7		5.77	7.36	6.34	10.48	9.08		1.92	2.06	2.06	10.01
EV/FCF						200.88	235.8											93.98	74.33	61.37			43.68	37.6				10.59	11.37	11.37	-22.89
Debt/EBITDA																		12.58	6.16	6.18			4.81	4.9	8.98	8.98		1.32	1.71	1.71	0.25
Netdebt/EBITDA																		4.79	-0.0326	-0.0124			0.4861	0.5738	0.1967	0.1967		0.004	0.0373	0.0373	-1.80
Debt/Ratio																				0.176	0.1988	0.1978	0.1426	0.145	0.1495	0.1495		0.1583	0.1496	0.1496	0.10
Debt/Equity																				0.3853	0.4149	0.4128	0.2895	0.2945	0.306	0.306		0.3554	0.5293	0.5293	0.56
Debt/Net Income																			18.3	18.36		12.89	6.29	6.41	40.53	40.53		2.74	2.98	2.98	-1.81
PEG																												-136.65	-124.34	-124.65	-1308.27
Beta																											0.5929	4.18	5.33	-0.0861	1.09
Altman Index							4.15	5.14	5.09	3.56	4.18	5.8															3.97	191.76	32.04	32.04	7.58

	Industry average	Average for 5 quarters	CAGR 5

Dividends

IFRS

Reporting Annual Quarterly

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Industry average	Average for 5 years	CAGR 5
Dividend payout, bln	0.2483	0.3982	0.45	0.7103	0.8197	1.19	0.9385	0.6327	1.71			0.4692
Dividend			0.0311	0.04	0.04	0.0533	0.04	0.1	0.08	0.06	0.09	0.09
Dividend yield, %			0.1805	0.1769	0.3038	0.3912	0.5621	3.25	4.24	1.55	0.9563	1.15	1.15
Dividends / profit, %		23.24	20.73	7.85	30.28	42.84	6.42	28.7	27.13	52.76		52.76	24.17
Dividend coverage ratio						4.63	11.52	6.98	1.39		6.88	6.88	3.17

	2018Q2	2018Q4	2019Q1	2019Q2	2019Q4	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q2	2022Q3	2022Q4	2023Q2	2023Q4	2025Q2	2025Q3	2025Q4	Industry average	Average for 5 quarters	CAGR 5
Dividend payout, bln	0.1776	0.2049	0.2049	0.2049					0.4692	0.4692	0.4692	0.4692			0.6338		0.5843
Dividend					0.0133	0.0133	0.02	0.02		0.02	0.02		0.04	0.06		0.06	0.02
Dividend yield, %					0.081	0.0718	0.1706	0.2593		0.2421	0.2986		0.9492	1.38		1.49	0.6121				1.15
Dividends / profit, %	29.87	2.99	23.92	34.87					24.52	5.53	15.31	3.21			-365.94		58.95				24.17
Dividend coverage ratio															-0.2733		1.7	7.46	6.88	6.88	3.17

	Industry average	Average for 5 quarters	CAGR 5

Other

IFRS

Reporting Annual Quarterly

	2020	2021	2022	2023	2024	LTM	CAGR 5
CAPEX/Revenue, %	7.86	7.05	6.71	6.51	4.82	4.84
Staff, people				26 272	26 079

	2022Q3	2022Q4	2023Q1	2023Q2	2023Q4	2024Q1	2024Q2	CAGR 5
CAPEX/Revenue, %	4.54	7.63	4.93	4.93	9.77	2.57	2.57

	CAGR 5

Investing Port

Sino Biopharmaceutical Limited

Reporting Sino Biopharmaceutical Limited

Reports

Capitalization

Balance sheet

Share

Efficiency

Coefficients

Dividends

Pay for your subscription

Other